Recent Advances of Drug Nano-carriers Based on Central Nervous System

GUO Zhi-Lei,CHE Xiao-Ming

DOI: https://doi.org/10.3969/j.issn.1008-0678.2009.03.024

2009-01-01

Abstract:Most of hydrophilic therapeutic agents,such as antibiotics,anticancer agents,or neuropeptides do not cross the blood brain barrier(BBB)after systemic administration.Drug modification,osmotic opening of cerebral capillary endothelium,and alternative routes for administration have been mostly used to enhance drug transport to the central nervous system(CNS).Through the use of nanocarriers,such as liposomes and solid polymeric or lipid nanoparticles can not only mask the BBB limiting characteristics of the therapeutic drug molecule,but also protect the drug from chemical/enzymatic degradation,and additionally provide the opportunity for sustained release characteristics.Reduction of toxicity to peripheral organs can also be achieved with these nanocarriers.The various barriers for drug delivery to the CNS and the current state of nanocarriers for enhancing drug transport into the CNS were reviewed.